Reports are examining the biopharma industry's outlook for 2025, with a focus on various aspects such as therapeutic area advances, artificial intelligence, and data science. The industry's state, funding, mergers and acquisitions, and partnering are also being discussed. The use of artificial intelligence in biopharma is a recurring theme, with some reports exploring its potential operational transformation and future applications.